EndoTex, Medtronic Carotid Stents Reveal Favorable Adverse Event Rates
EndoTex's NexStent carotid stent major adverse event rate of 3.8% at 30 days compares favorably with MAE rates in the 7%-8%-range for competing systems
EndoTex's NexStent carotid stent major adverse event rate of 3.8% at 30 days compares favorably with MAE rates in the 7%-8%-range for competing systems